Stocktoria
Alto Neuroscience, Inc. ANRO
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2024-02-02
Alto Neuroscience, Inc. statistics & valuation
Market cap$948.9M
P / B6.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -34.2% | -34.6% | -41.9% |
| Return on equity | -41.8% | -40.6% | 50.7% |
| Debt / equity | 0.11× | 0.07× | -0.14× |
| Current ratio | 15.69 | 16.92 | 15.22 |
Source: SEC EDGAR filings · CIK 0001999480 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.